Pharmacological cardioprotection of the human myocardium in diseased states
Background: Coronary artery disease is the leading worldwide cause of death. Even despite restoration of blood flow following acute myocardial infarction, further myocardial damage is seen during the reperfusion phase. Pharmacological strategies to induce resistance to ischaemia reperfusion injury h...
Main Author: | Rees, P. S. C. |
---|---|
Published: |
University College London (University of London)
2011
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.587618 |
Similar Items
-
Apelin : a cardioprotective adipocytokine
by: Simpkin, J. C.
Published: (2007) -
The role of DJ-1 in cardioprotection
by: Mukherjee, U. A.
Published: (2013) -
Investigation of mitochondrial targets for cardioprotection
by: Dongworth, R. K.
Published: (2013) -
The cardioprotective mechanisms of dietary flavonoids
by: Daubney, J.
Published: (2015) -
The relationship between changes in myocardial resistivity, conduction velocity and gap-junction topology in diseased human myocardium
by: Dhillon, Paramdeep Singh
Published: (2009)